• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复杂腹腔内感染管理中的经验性治疗选择。

Empiric treatment options in the management of complicated intra-abdominal infections.

作者信息

Weigelt John A

机构信息

Department of Surgery, Division of Trauma/Critical Care, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

出版信息

Cleve Clin J Med. 2007 Aug;74 Suppl 4:S29-37. doi: 10.3949/ccjm.74.suppl_4.s29.

DOI:10.3949/ccjm.74.suppl_4.s29
PMID:17847176
Abstract

Complicated intra-abdominal infections remain a major challenge for surgeons and internists because of their association with high morbidity and mortality. For optimal outcome, these infections require a combination of appropriate and timely surgical source control and adjunctive broad-spectrum antimicrobial therapy. This review discusses criteria for choosing empiric antimicrobial therapy, outlines available treatment options, and highlights new antimicrobial therapies for these infections.

摘要

复杂性腹腔内感染因其与高发病率和死亡率相关,仍然是外科医生和内科医生面临的重大挑战。为了获得最佳治疗效果,这些感染需要适当且及时的手术源头控制与辅助性广谱抗菌治疗相结合。本综述讨论了选择经验性抗菌治疗的标准,概述了可用的治疗方案,并强调了针对这些感染的新型抗菌治疗方法。

相似文献

1
Empiric treatment options in the management of complicated intra-abdominal infections.复杂腹腔内感染管理中的经验性治疗选择。
Cleve Clin J Med. 2007 Aug;74 Suppl 4:S29-37. doi: 10.3949/ccjm.74.suppl_4.s29.
2
Empiric treatment of nosocomial intra-abdominal infections: a focus on the carbapenems.医院获得性腹腔内感染的经验性治疗:聚焦碳青霉烯类药物
Surg Infect (Larchmt). 2005 Fall;6(3):329-43. doi: 10.1089/sur.2005.6.329.
3
Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp.替加环素治疗广泛耐药不动杆菌属引起的感染的临床经验。
Microb Drug Resist. 2012 Dec;18(6):562-6. doi: 10.1089/mdr.2012.0010. Epub 2012 Jul 9.
4
Antimicrobial management in nosocomial peritonitis: microbiota, drug and time.医院内腹膜炎的抗菌管理:微生物群、药物与时间
Rev Esp Quimioter. 2017 Sep;30 Suppl 1:34-38.
5
In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.黏菌素、替加环素和多尼培南抗生素组合对广泛耐药和多重耐药鲍曼不动杆菌的体外相互作用
Ann Lab Med. 2016 Mar;36(2):124-30. doi: 10.3343/alm.2016.36.2.124.
6
[New options for treatment of intraabdominal infections: tigecycline].[腹腔内感染治疗的新选择:替加环素]
Infez Med. 2008 Feb;16 Suppl 1:53-6.
7
Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections--are they applicable today?复杂皮肤及软组织感染与腹腔内感染指南综述——它们如今是否适用?
Clin Microbiol Infect. 2008 Dec;14 Suppl 6:9-18. doi: 10.1111/j.1469-0691.2008.02123.x.
8
[Antibiotic treatment of peritonitis].[腹膜炎的抗生素治疗]
J Chir (Paris). 1999 Mar;136(1):15-20.
9
[In vitro tigecycline and carbapenem susceptibilities of clinical Acinetobacter baumannii isolates].[临床鲍曼不动杆菌分离株对替加环素和碳青霉烯类药物的体外敏感性]
Mikrobiyol Bul. 2010 Oct;44(4):641-5.
10
[Doripenem: need for a new carbapenem].多利培南:新型碳青霉烯类药物的需求
Med Mal Infect. 2009 Dec;39(12):871-6. doi: 10.1016/j.medmal.2009.08.014. Epub 2009 Oct 28.

引用本文的文献

1
Transfer factor treatment in management of peritonitis condition: An experimental study in rat.转移因子治疗腹膜炎病症:大鼠实验研究
Ann Med Surg (Lond). 2021 Aug 25;69:102755. doi: 10.1016/j.amsu.2021.102755. eCollection 2021 Sep.
2
Novel Beta-Lactam/Beta-Lactamase Plus Metronidazole vs Carbapenem for Complicated Intra-abdominal Infections: A Meta-analysis of Randomized Controlled Trials.新型β-内酰胺/β-内酰胺酶抑制剂联合甲硝唑与碳青霉烯类治疗复杂性腹腔内感染:一项随机对照试验的荟萃分析
Open Forum Infect Dis. 2020 Dec 8;8(1):ofaa591. doi: 10.1093/ofid/ofaa591. eCollection 2021 Jan.
3
Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017.
2013 年至 2017 年全球临床实验室分离的革兰氏阴性杆菌对依拉环素的活性。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.01699-19.
4
Antimicrobial susceptibilities of specific syndromes created with organ-specific weighted incidence antibiograms (OSWIA) in patients with intra-abdominal infections.特定综合征的抗菌药敏谱,采用器官特异性加权发病率抗生素图谱(OSWIA),对腹腔内感染患者进行评估。
BMC Infect Dis. 2018 Nov 19;18(1):584. doi: 10.1186/s12879-018-3494-x.
5
Assessment of Severity of Peritonitis Using Mannheim Peritonitis Index.使用曼海姆腹膜炎指数评估腹膜炎的严重程度。
Niger J Surg. 2016 Jul-Dec;22(2):118-122. doi: 10.4103/1117-6806.189009.
6
CT differentiation between tubo-ovarian and appendiceal origin of right lower quadrant abscess: CT, clinical, and laboratory correlation.CT鉴别右下象限脓肿的输卵管卵巢起源与阑尾起源:CT、临床及实验室相关性
Emerg Radiol. 2016 Apr;23(2):133-9. doi: 10.1007/s10140-015-1372-z. Epub 2015 Dec 30.
7
[Antibiotic therapy of intra-abdominal infections in the era of multiresistance].多重耐药时代腹腔内感染的抗生素治疗
Chirurg. 2016 Jan;87(1):26-33. doi: 10.1007/s00104-015-0106-9.
8
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.2012年和2013年中国七个地区腹腔感染患者中需氧和兼性革兰氏阴性杆菌的药敏情况
Antimicrob Agents Chemother. 2015 Oct 19;60(1):245-51. doi: 10.1128/AAC.00956-15. Print 2016 Jan.
9
Colorectal cancer with intestinal perforation - a retrospective analysis of treatment outcomes.伴有肠穿孔的结直肠癌——治疗结果的回顾性分析
Contemp Oncol (Pozn). 2014;18(6):414-8. doi: 10.5114/wo.2014.46362. Epub 2014 Dec 31.
10
Efficacy and safety of moxifloxacin in hospitalized patients with secondary peritonitis: pooled analysis of four randomized phase III trials.莫西沙星治疗继发性腹膜炎住院患者的疗效与安全性:四项随机III期试验的汇总分析
Surg Infect (Larchmt). 2014 Oct;15(5):567-75. doi: 10.1089/sur.2013.045. Epub 2014 May 15.